+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dupuytren Contracture Drug"

From
Dupuytren Contracture - Epidemiology Forecast - 2032 - Product Thumbnail Image

Dupuytren Contracture - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Dupuytren Contracture - Pipeline Insight, 2024 - Product Thumbnail Image

Dupuytren Contracture - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Dupuytren Contracture Drug market is a subset of the larger Musculouskeletal Disorders Drugs market. It is focused on treatments for Dupuytren Contracture, a condition that affects the connective tissue in the palm of the hand and can cause the fingers to curl inwards. Treatment options include surgery, collagenase injections, and radiation therapy. Collagenase injections are the most common treatment for Dupuytren Contracture, and the market is dominated by a few major players. Companies in the market include Auxilium Pharmaceuticals, Endo Pharmaceuticals, and BioSpecifics Technologies. Other companies, such as Ferring Pharmaceuticals, have recently entered the market with their own collagenase injection products. Show Less Read more